Press Releases

The following are official statements issued by UsAgainstAlzheimer’s in response to major national policy actions, industry events, breaking news, or organizational achievements. Please see the UsAgainstAlzheimer’s press kit page for additional information. For media requests, please contact Jon Summers at [email protected].

  • January 25, 2021

    Partnership Launched to Fight Alzheimer’s Worldwide

    COVID-19 will be the priority for health systems around the world in...

    Read more
  • January 28, 2021

    UsAgainstAlzheimer’s Survey Shows Alzheimer’s Patients Value a New Therapy that Slows Progression of Symptoms

    A new UsAgainstAlzheimer’s A-LIST® survey shows that about eight in 10 people in the early stages of...

    Read more
  • January 21, 2021

    Paid Leave Alliance for Dementia Caregivers Applauds American Rescue Plan but Urges Action on Paid Leave Support for Caregivers of Older Adults

    We are heartened to see the Biden-Harris administration make support for working...

    Read more
  • January 11, 2021

    UsAgainstAlzheimer's Statement on Donanemab

    UsAgainstAlzheimer’s (UsA2) today issued the following statement from George Vradenburg, chairman and...

    Read more
  • December 21, 2020

    UsAgainstAlzheimer’s Applauds $300 Million Increase for Alzheimer’s Research at NIH Contained in Final 2021 Spending Bill

    Thanks Congress for Bipartisan Support for Groundbreaking Alzheimer’s Research

    Read more
  • December 03, 2020

    UsAgainstAlzheimer’s Announces New Brain Health Equity Solutions

    Washington, D.C. (December 3, 2020) – UsAgainstAlzheimer’s today announced several new efforts...

    Read more
  • November 17, 2020

    New Report Reveals Deep Social Inequities in Counties Hard Hit by Alzheimer’s Disease Among Blacks and Latinos

    Report from UsAgainstAlzheimer’s and Urban Institute highlights the importance of addressing the...

    Read more
  • November 10, 2020

    UsAgainstAlzheimer’s Praises Senate Appropriations Committee’s Proposed $354 Million Increase for Alzheimer’s Research at NIH

    Washington, D.C. (November 10, 2020) – George Vradenburg, chairman and co-founder of...

    Read more
  • November 06, 2020

    UsAgainstAlzheimer’s Urges FDA to Approve Aducanumab to Give More Time and New Hope to People with Early Stage Alzheimer’s

    Washington, D.C. (November 6, 2020) – UsAgainstAlzheimer’s (UsA2) today called for federal...

    Read more

Place & Brain Health Equity: Understanding the County-Level Impacts of Alzheimer’s

The effects of where people live, and the social determinants of health are under-recognized and under-appreciated in our national response to effectively treat and prevent Alzheimer's. This report found that deep social inequities exist in countries highly impacted by Alzheimer's among Latinos and Blacks.

Read Report